2-anthramine has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Burgueño-Tapia, E; Cornejo-Garrido, J; Domínguez-Mendoza, EA; Ordaz-Pichardo, C | 1 |
| Gato, WE; McHale, BJ; Pierre, TH; Pilz, Z; Reynolds, AS; Seise, I | 1 |
| Bogan, B; Gato, WE; Kusi, MY; McHale, BJ; Pilz, ZA; Seise, I | 1 |
3 other study(ies) available for 2-anthramine and Alloxan Diabetes
| Article | Year |
|---|---|
Antidiabetic effect, antioxidant activity, and toxicity of 3',4'-Di-O-acetyl-cis-khellactone in Streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Catalase; Coumarins; Diabetes Mellitus, Experimental; Glutathione; Glutathione Peroxidase; Hypoglycemic Agents; Insulin; Islets of Langerhans; Liver; Mutagenicity Tests; Oxidative Stress; Rats; Salmonella typhimurium; Streptozocin; Superoxide Dismutase | 2016 |
Evaluation of renal markers of T1D in Sprague-Dawley exposed to 2-aminoanthracene.
Topics: Animals; Anthracenes; Biomarkers; Blood Glucose; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Fatty Acid-Binding Proteins; Kidney; Male; Organ Size; Rats; Rats, Sprague-Dawley; Serum Albumin | 2020 |
Dietary ingestion of 2-aminoanthracene (2AA) and the risk for type-1 diabetes (T1D).
Topics: Animals; Anthracenes; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dietary Exposure; Environmental Pollutants; Insulin-Secreting Cells; Interleukins; Male; Rats; Rats, Sprague-Dawley; Risk | 2020 |